Leo Pharma in-licenses new psoriasis therapy - Zenopa

Leo Pharma in-licenses new psoriasis therapy Zenopa Leo Pharma has declared a new in-licensing deal for an innovative spoken treatment for psoriasis from biotech company Virobay. The multimillion-dollar collaborative arrangement faculty see the companies partnering on the development of a compound that is ... LEO Pharma Inc. Debuts LEO® Quality aid Program for Plaque disease of the skin Patients EON: Enhanced Online News (press release) Lion Pharma Inc. Debuts LEO(R) Quality Care Program for Plaque Psoriasis Patients MarketWatch (press release) all vi news articles » Link To Article